Vaughan Nelson Investment Management’s Globus Medical GMED Stock Holding History

Vaughan Nelson Investment Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21.5M	Buy	+271,497	New	+$23.1M	0.19%	139
2025 Q3	–	Sell	-582,562	Closed	-$34.4M	–	210
2025 Q2	$34.4M	Sell	582,562 -148,630	-20%	-$9.6M	0.32%	99
2025 Q1	$53.5M	Buy	731,192 +51,600	+8%	+$4.26M	0.54%	66
2024 Q4	$56.2M	Sell	679,592 -379,880	-36%	-$30M	0.52%	68
2024 Q3	$75.8M	Sell	1,059,472 -77,225	-7%	-$5.45M	0.67%	41
2024 Q2	$77.9M	Buy	1,136,697 +172,605	+18%	+$10.3M	0.72%	34
2024 Q1	$51.7M	Buy	964,092 +194,900	+25%	+$10.5M	0.45%	69
2023 Q4	$41M	Buy	769,192 +207,172	+37%	+$10.1M	0.41%	82
2023 Q3	$27.9M	Buy	+562,020	New	+$31.4M	0.32%	94
2020 Q2	–	Sell	-364,280	Closed	-$15.5M	–	196
2020 Q1	$15.5M	Buy	+364,280	New	+$18M	0.26%	118

Other funds holding GMED

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Pembroke Management Montreal, Quebec, Canada $637M AUM 40.98% 1-Year Est. Return

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Terril Brothers St. Louis, Missouri $388M AUM 29.38% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Vaughan Nelson Investment Management's GMED Position: Q2 2026 in Review

Vaughan Nelson Investment Management opened a new position in Globus Medical (GMED) in Q2 2026: 271,497 shares worth $21.5M. The stake represents 0.19% of the portfolio and ranks #139 among its holdings. This is a return to the name: Vaughan Nelson Investment Management previously reported a position in GMED as recently as Q2 2025.

Vaughan Nelson Investment Management first reported a position in GMED in Q1 2020 and has held it in 10 quarters since. The position peaked at $77.9M in Q2 2024. 129 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

Vaughan Nelson Investment Management held 271,497 shares of Globus Medical worth $21.5M as of Q2 2026.
Globus Medical was a new Vaughan Nelson Investment Management position in Q2 2026.
Globus Medical made up 0.19% of Vaughan Nelson Investment Management's portfolio in Q2 2026, its #139 holding.
Vaughan Nelson Investment Management first reported a position in Globus Medical in Q1 2020 and has held it in 10 quarters since.
Vaughan Nelson Investment Management's Globus Medical position peaked at $77.9M in Q2 2024.
129 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Vaughan Nelson Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.